Prevas

Prevas

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Prevas - Waiting for volumes to follow

01 juli 2026

  • Signs of stabilisation but pricing remains pressured
  • We leave our estimates broadly unchanged
  • Trading ~25% below Nordic peers

A stabilising market, but pricing remains the challenge

The technical consulting market has been weaker for longer than most expected. We believe conditions are gradually stabilising, although a meaningful recovery in volumes will likely take time. As reflected in recent market KPIs, Sweden is showing tentative signs of improvement, while Denmark remains challenging following large layoffs at major corporates. We therefore expect Denmark to remain a headwind despite Prevas' continued capacity adjustments. We estimate Q2 sales of SEK 407m, corresponding to flat y-o-y growth, driven primarily by acquisitions, while organic growth is likely to remain slightly negative. We estimate adj. EBITA of SEK 28m, corresponding to a 6.9% margin (6.5% in Q2'25), as continued cost discipline should partly offset persistent pricing pressure and higher salary costs following the annual wage revisions.

Limited changes to estimates

We make only limited changes to our estimates. Defence demand remains strong, supported by long project durations and high barriers to entry, while the company's EAM offering continues to gain traction through long-term customer relationships.

Trading 25% below its peers

Prevas is trading at 8x EV/EBITA on our '26 estimates, around 25% below the Nordic engineering consultancy peer group, despite offering higher margins and stronger long-term growth prospects, in our view. Near-term visibility remains limited, and pricing pressure is likely to persist until demand improves more meaningfully. However, we continue to believe that Prevas' niche positioning, high degree of specialisation and exposure to structurally growing end-markets should allow the company to outperform peers once the consulting cycle turns.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Svedbergs Group - Logistics drag persists into H2 Svedbergs G.. Analys
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys